Literature DB >> 22613792

Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.

Gary E Gilbert1, Valerie A Novakovic, Randal J Kaufman, Hongzhi Miao, Steven W Pipe.   

Abstract

Factor VIII and factor V share structural homology and bind to phospholipid membranes via tandem, lectin-like C domains. Their respective C2 domains bind via 2 pairs of hydrophobic amino acids and an amphipathic cluster. In contrast, the factor V-like, homologous subunit (Pt-FV) of a prothrombin activator from Pseudonaja textilis venom is reported to function without membrane binding. We hypothesized that the distinct membrane-interactive amino acids of these proteins contribute to the differing membrane-dependent properties. We prepared mutants in which the C2 domain hydrophobic amino acid pairs were changed to the homologous residues of the other protein and a factor V mutant with 5 amino acids changed to those from Pt-FV (FV(MTTS/Y)). Factor VIII mutants were active on additional membrane sites and had altered apparent affinities for factor X. Some factor V mutants, including FV(MTTS/Y), had increased membrane interaction and apparent membrane-independent activity that was the result of phospholipid retained during purification. Phospholipid-free FV(MTTS/Y) showed increased activity, particularly a 10-fold increase in activity on membranes lacking phosphatidylserine. The reduced phosphatidylserine requirement correlated to increased activity on resting and stimulated platelets. We hypothesize that altered membrane binding contributes to toxicity of Pt-FV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613792      PMCID: PMC3433094          DOI: 10.1182/blood-2012-01-408245

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations.

Authors:  Mettine H A Bos; Michael Boltz; Liam St Pierre; Paul P Masci; John de Jersey; Martin F Lavin; Rodney M Camire
Journal:  Blood       Date:  2009-04-13       Impact factor: 22.113

2.  Complete cDNA and derived amino acid sequence of human factor V.

Authors:  R J Jenny; D D Pittman; J J Toole; R W Kriz; R A Aldape; R M Hewick; R J Kaufman; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis.

Authors:  S W Kim; M A Quinn-Allen; J T Camp; S Macedo-Ribeiro; P Fuentes-Prior; W Bode; W H Kane
Journal:  Biochemistry       Date:  2000-02-29       Impact factor: 3.162

4.  Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII.

Authors:  P C Spiegel; M Jacquemin; J M Saint-Remy; B L Stoddard; K P Pratt
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

5.  Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque.

Authors:  Natalya M Ananyeva; Diana V Kouiavskaia; Midori Shima; Evgueni L Saenko
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

6.  The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.

Authors:  Rinku Majumder; Mary Ann Quinn-Allen; William H Kane; Barry R Lentz
Journal:  Biochemistry       Date:  2005-01-18       Impact factor: 3.162

7.  The tertiary structure and domain organization of coagulation factor VIII.

Authors:  Betty W Shen; Paul Clint Spiegel; Chong-Hwan Chang; Jae-Wook Huh; Jung-Sik Lee; Jeanman Kim; Young-Ho Kim; Barry L Stoddard
Journal:  Blood       Date:  2007-10-26       Impact factor: 22.113

8.  Kinetics of factor VIII-von Willebrand factor association.

Authors:  A J Vlot; S J Koppelman; J C Meijers; C Dama; H M van den Berg; B N Bouma; J J Sixma; G M Willems
Journal:  Blood       Date:  1996-03-01       Impact factor: 22.113

9.  Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine.

Authors:  P Comfurius; E F Smeets; G M Willems; E M Bevers; R F Zwaal
Journal:  Biochemistry       Date:  1994-08-30       Impact factor: 3.162

10.  Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.

Authors:  T L Ortel; D Devore-Carter; M Quinn-Allen; W H Kane
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

View more
  16 in total

1.  Factor VIII Interacts with the Endocytic Receptor Low-density Lipoprotein Receptor-related Protein 1 via an Extended Surface Comprising "Hot-Spot" Lysine Residues.

Authors:  Maartje van den Biggelaar; Jesper J Madsen; Johan H Faber; Marleen G Zuurveld; Carmen van der Zwaan; Ole H Olsen; Henning R Stennicke; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2015-04-21       Impact factor: 5.157

2.  Procoagulant activities of skeletal and cardiac muscle myosin depend on contaminating phospholipid.

Authors:  Valerie A Novakovic; Gary E Gilbert
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

3.  Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII.

Authors:  Wei Wei; Saurav Misra; Matthew V Cannon; Renchi Yang; Xiaofan Zhu; Reid Gilmore; Min Zhu; Bin Zhang
Journal:  Biochem J       Date:  2018-03-06       Impact factor: 3.857

4.  Structure of the factor VIII C2 domain in a ternary complex with 2 inhibitor antibodies reveals classical and nonclassical epitopes.

Authors:  Justin D Walter; Rachel A Werther; Caileen M Brison; Rebecca K Cragerud; John F Healey; Shannon L Meeks; Pete Lollar; P Clint Spiegel
Journal:  Blood       Date:  2013-10-01       Impact factor: 22.113

5.  Membrane Interaction of the Factor VIIIa Discoidin Domains in Atomistic Detail.

Authors:  Jesper J Madsen; Y Zenmei Ohkubo; Günther H Peters; Johan H Faber; Emad Tajkhorshid; Ole H Olsen
Journal:  Biochemistry       Date:  2015-09-30       Impact factor: 3.162

6.  Deep mutational scanning: a new style of protein science.

Authors:  Douglas M Fowler; Stanley Fields
Journal:  Nat Methods       Date:  2014-08       Impact factor: 28.547

7.  The 1.7 Å X-ray crystal structure of the porcine factor VIII C2 domain and binding analysis to anti-human C2 domain antibodies and phospholipid surfaces.

Authors:  Caileen M Brison; Steven M Mullen; Michelle E Wuerth; Kira Podolsky; Matthew Cook; Jacob A Herman; Justin D Walter; Shannon L Meeks; P Clint Spiegel
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

8.  Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII.

Authors:  Wei Wei; Chunlei Zheng; Min Zhu; Xiaofan Zhu; Renchi Yang; Saurav Misra; Bin Zhang
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

9.  Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.

Authors:  Eduard H T M Ebberink; Eveline A M Bouwens; Esther Bloem; Mariëtte Boon-Spijker; Maartje van den Biggelaar; Jan Voorberg; Alexander B Meijer; Koen Mertens
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

10.  Dissection of pleiotropic effects of variants in and adjacent to F8 exon 19 and rescue of mRNA splicing and protein function.

Authors:  Silvia Lombardi; Gabriele Leo; Simone Merlin; Antonia Follenzi; John H McVey; Iva Maestri; Francesco Bernardi; Mirko Pinotti; Dario Balestra
Journal:  Am J Hum Genet       Date:  2021-07-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.